MagForce AG / MagForce to Present at Two Investor Conferences in the US . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
Berlin, Germany, May 14, 2013 - MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company in the field of nanomedicine in oncology, announced today that the Company will present at two upcoming investor conferences in the US:
Bank of America Merrill Lynch 2013 Health Care Conference
Date: May 16, 2013, 08:00 am PDT (05:00 pm CEST, 04:00 pm BST)
Venue: Encore at Wynn, Las Vegas, NV, USA
Presenter: Prof. Dr. Hoda Tawfik, COO and co-CEO of MagForce AG
IN3 Medical Device 360° Boston
Date: June 25, 2013, 04:20 pm EDT (10:20 pm CEST, 09:20 pm BST)
Venue: Hyatt Regency Boston, MA, USA
Presenter: Prof. Dr. Hoda Tawfik, COO and co-CEO of MagForce AG
The PDF version of the presentation will be provided at www.magforce.com (http://www.magforce.com/).
About MagForce AG
MagForce AG is a leading medical technology company in the field of nanomedicine in oncology. The Company's proprietary, NanoTherm® therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator(TM) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm®, NanoPlan®, and NanoActivator(TM) are trademarks of MagForce AG in selected countries. For more information, please visit www.magforce.com (http://www.magforce.com/).
Disclaimer
This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: MagForce AG via Thomson Reuters ONE
--- End of Message ---
MagForce AG
Max-Dohrn-Str. 8 Berlin Germany
WKN: A0HGQF;ISIN: DE000A0HGQF5;
Listed: Open Market (Freiverkehr) in Frankfurter Wertpapierbörse;
